Bevacizumab: all 1,786 studies that test it
Page 15 of 18. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.
- A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast CancerCompletedNCT01142778Phase 2
- A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid TumorsCompletedNCT01139723Phase 1
- Metronomic Therapy in Metastatic Breast Cancer.CompletedNCT01131195Phase 3
- LUCAS (Lucentis Compared to Avastin Study)CompletedNCT01127360Phase 4
- Paclitaxel Plus Bevacizumab for Older Patients With Breast CancerTerminatedNCT01120158Phase 2
- Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).CompletedNCT01116219Phase 2
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable GlioblastomaCompletedNCT01102595Phase 2
- Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular OedemaTerminatedNCT01095809Phase 3
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast CancerStatus unknownNCT01093235Phase 3
- Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous HemorrhageStatus unknownNCT01091896Phase 2
- Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)CompletedNCT01091792Early Phase 1
- Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerTerminatedNCT01090830Phase 1/2
- Radiosurgery Plus Bevacizumab in GlioblastomaTerminatedNCT01086345Early Phase 1
- Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular SchwannomaSuspendedNCT01083966Phase 1
- Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast CancerTerminatedNCT01069796Phase 2
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.Status unknownNCT01067053Phase 2
- Pilot Study of Bevacizumab (Avastin) in Patients With Septic ShockWithdrawnNCT01063010Not applicable
- HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
- Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01057212Phase 2
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade GliomasWithdrawnNCT01052363Phase 1
- A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaCompletedNCT01051934Phase 1
- Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous SystemCompletedNCT01048554Phase 2
- Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein OcclusionStatus unknownNCT01044329Phase 2
- Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal CancerCompletedNCT01043484Phase 2
- Efficacy of PreOperative Bevacizumab for Diabetic Eye DiseaseCompletedNCT01041690Not applicable
- Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular DegenerationCompletedNCT01032109Not applicable
- Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic RetinopathyCompletedNCT01025934Phase 4
- Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast CancerCompletedNCT01025349Phase 2
- Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01024504Phase 2
- Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable GlioblastomaCompletedNCT01022918Phase 2
- Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
- Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau DiseaseTerminatedNCT01015300Early Phase 1
- Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
- Bevacizumab Versus Ranibizumab in Age Related Macular DegenerationStatus unknownNCT01014468Phase 3
- Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular EdemaStatus unknownNCT00999791Phase 1
- Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)CompletedNCT00997191Phase 3
- Bevacizumab for the Treatment of Corneal NeovascularizationStatus unknownNCT00992849Phase 2
- Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma MultiformeWithdrawnNCT00984438Phase 1/2
- A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00974584Phase 1
- S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by SurgeryStatus unknownNCT00974389Phase 2
- Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)CompletedNCT00973609Phase 3
- Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein OcclusionCompletedNCT00970957Phase 3
- Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)CompletedNCT00968240Phase 1
- A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast CancerCompletedNCT00960960Phase 1
- A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer EarlyStatus unknownNCT00957125Phase 2
- Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00952029Phase 2/3
- Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer PatientsCompletedNCT00952003Phase 2
- Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow MicrometastasesCompletedNCT00949247Early Phase 1
- OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00940303Phase 2
- Bevacizumab and VasoconstrictionCompletedNCT00929058Not applicable
- A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent GliomasCompletedNCT00921167Phase 2
- XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
- TC Avastin. ICORG 08-10, V6CompletedNCT00911716Not applicable
- Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer RectumCompletedNCT00909987Phase 2
- A Study of Bevacizumab to Prevent Malignant AscitesWithdrawnNCT00908219Phase 2
- Bevacizumab for Central Retinal Vein Occlusion StudyCompletedNCT00906685Phase 3
- Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma MultiformeStatus unknownNCT00906516Phase 2
- A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine GliomasCompletedNCT00890786Early Phase 1
- Safety/Biomarker Study of CNTO 95 and Avastin in Solid TumorsCompletedNCT00888043Phase 1
- A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerCompletedNCT00887536Phase 3
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00885326Phase 1
- Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsCompletedNCT00875771Phase 2
- Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular EdemaCompletedNCT00874744Phase 2
- A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal CancerCompletedNCT00873756Phase 1
- Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal CancerCompletedNCT00873275Phase 1
- Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)CompletedNCT00862342Phase 2
- To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.CompletedNCT00861419Phase 1
- Subconjunctival Bevacizumab Effect on Bleb VascularityStatus unknownNCT00854529Phase 2
- A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)CompletedNCT00851136Phase 1
- Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal CancerCompletedNCT00851045Phase 2
- Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerTerminatedNCT00850577Phase 2
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- Xeloda and Bevacizumab to Treat Rectal CancerCompletedNCT00847119Phase 2
- Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerCompletedNCT00846612Phase 1
- Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric CancerStatus unknownNCT00845884Phase 1/2
- Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWithdrawnNCT00845104Phase 2
- Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II StudyCompletedNCT00843440Phase 2
- Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II StudyStatus unknownNCT00842686Phase 2
- Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer PatientsCompletedNCT00820547Phase 2
- Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)CompletedNCT00817284Phase 2
- Bleb Vascularity Change After Subconjunctival Injection BevacizumabStatus unknownNCT00815594Phase 4
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Combined Triple Therapy in Diabetic Retinopathy (DRP)CompletedNCT00806169Phase 3
- Combined Triple Procedure in Retinal Vein Occlusion (RVO)CompletedNCT00805064Phase 3
- Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabCompletedNCT00804921Phase 2
- Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid CancerTerminatedNCT00804830Phase 2
- Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal PhotocoagulationTerminatedNCT00804206Phase 4
- Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)CompletedNCT00802906Not applicable
- Avastin for Post-photocoagulation Macular EdemaWithdrawnNCT00801866Phase 4
- A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma MultiformeCompletedNCT00800917Phase 2
- The Effect of Bevacizumab on Corneal NeovascularizationCompletedNCT00797303Phase 4
- R-CHOP-B Bevacizumab for Diffuse Large B Cell LymphomaTerminatedNCT00788606Phase 2
- A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid TumorsCompletedNCT00786669Phase 1
- Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)CompletedNCT00781846Phase 1
- Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
- Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001CompletedNCT00775073Phase 2